CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Nordic Society for Pediatric Hematology and Oncology

Academic/HospitalWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Oct 1, 2016

Timeline

2010s

Jan 1, 2013
Nordic Society for Pediatric Hematology and Oncology— Founded

Drugs by trial phase (7 distinct, 6 trials)

Phase 4 (1 own, 0 via acquisition)

pegaspargase

Phase 3 (5 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

tioguanine

Indications

Studied for

Recent trials (8)

NCT02912676CollaboratorPhase 1/Phase 2Oct 1, 2016
NCT00816049CollaboratorPhase 3Jan 1, 2009
NCT00991744Lead sponsorPhase 3Jan 1, 2009
NCT00819351CollaboratorPhase 3Jan 1, 2009
NCT00991744Reponsible party - principal investigatorPhase 3Jan 1, 2009
NCT01305655Reponsible party - principal investigatorPhase 3Jul 1, 2008
NCT01305655Lead sponsorPhase 3Jul 1, 2008
NCT00192673Lead sponsorPhase 4Jun 1, 2005

Details

Founded: Stockholm, SE Jan 1, 2013
Last known activity: Oct 1, 2016